Bertha H Chen, MD
Obstetrics/Gynecology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G76784 · Current
Licensed to practise in California · since 1993 · expires 2026-12-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$32,639
Medicare paid this office $32,639 for 128 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 50 | $5,522 | $85 |
| Return visit (30+ min) | 16 | $2,791 | $121 |
| New patient visit (45+ min) | 22 | $2,047 | $93 |
| Short return visit (20+ min) | 33 | $1,876 | $54 |
| New patient visit (60+ min) | 14 | $1,716 | $123 |
See all 7 services
| Return visit (30+ min) | 50 | $5,522 | $85 |
| Return visit (30+ min) | 16 | $2,791 | $121 |
| New patient visit (45+ min) | 22 | $2,047 | $93 |
| Short return visit (20+ min) | 33 | $1,876 | $54 |
| New patient visit (60+ min) | 14 | $1,716 | $123 |
| Long return visit (40+ min) | 12 | $1,389 | $99 |
| Fitting and insertion of vaginal support device | 15 | $516 | $32 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
128 Original Medicare patients in 2024. Average age 76 · Women 100% · Health risk score 0.91. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 60% · Cancer 19% · Diabetes 17% · Coronary heart disease 16% · Depression 16% · Chronic kidney disease 11%.
The office billed $214,925, Medicare allowed $44,099 and paid $32,639; for 278 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 128 | 278 | 76 | 0.91 | $214,925 | $32,639 |
| 2023 | 156 | 364 | 76 | 0.95 | $268,151 | $49,240 |
| 2022 | 110 | 216 | 76 | 0.84 | $150,384 | $26,976 |
| 2021 | 197 | 518 | 75 | 0.87 | $319,627 | $63,461 |
| 2020 | 148 | 310 | 74 | 1.09 | $122,684 | $26,955 |
| 2019 | 207 | 583 | 75 | 1.01 | $258,830 | $53,563 |
| 2018 | 198 | 527 | 73 | 1.10 | $267,940 | $52,673 |
| 2017 | 174 | 469 | 74 | 1.06 | $210,940 | $42,299 |
| 2016 | 115 | 251 | 73 | 0.88 | $124,457 | $23,592 |
| 2015 | 112 | 266 | 74 | 0.91 | $144,953 | $26,133 |
| 2014 | 117 | 222 | 73 | 0.89 | $112,543 | $21,347 |
| 2013 | 128 | 341 | 72 | 0.96 | $143,927 | $26,676 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 62 | $6,555 | $84 |
| Long return visit (40+ min) | 31 | $5,053 | $133 |
| New patient visit (45+ min) | 44 | $4,731 | $108 |
| Short return visit (20+ min) | 44 | $2,710 | $52 |
| New patient visit (60+ min) | 15 | $2,305 | $154 |
| Fitting and insertion of vaginal support device | 30 | $1,080 | $34 |
2022: 5 services
| Return visit (30+ min) | 50 | $5,036 | $87 |
| Short return visit (20+ min) | 41 | $2,583 | $57 |
| Long return visit (40+ min) | 13 | $1,680 | $120 |
| New patient visit (45+ min) | 12 | $1,359 | $113 |
| Fitting and insertion of vaginal support device | 11 | $374 | $29 |
2021: 9 services
| Long return visit (40+ min) | 51 | $9,244 | $123 |
| Return visit (30+ min) | 68 | $7,314 | $82 |
| New patient visit (45+ min) | 63 | $6,774 | $108 |
| Short return visit (20+ min) | 64 | $4,420 | $52 |
| New patient visit (60+ min) | 24 | $3,937 | $164 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 16 | $1,856 | $116 |
| Fitting and insertion of vaginal support device | 22 | $700 | $25 |
| Insertion of device into abdomen with pressure and urine flow rate study | 16 | $582 | $36 |
| Electronic assessment of bladder emptying | 17 | $71 | $4 |
2020: 5 services
| New patient visit (45+ min) | 46 | $5,051 | $110 |
| Return visit (30+ min) | 54 | $4,151 | $72 |
| Short return visit (20+ min) | 64 | $3,624 | $43 |
| Long return visit (40+ min) | 14 | $1,463 | $98 |
| Fitting and insertion of vaginal support device | 19 | $432 | $21 |
2019: 10 services
| Return visit (30+ min) | 83 | $7,732 | $70 |
| New patient visit (45+ min) | 64 | $7,110 | $111 |
| Short return visit (20+ min) | 89 | $5,154 | $43 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 26 | $2,890 | $111 |
| Long return visit (40+ min) | 28 | $2,827 | $97 |
| New patient visit (60+ min) | 12 | $1,780 | $148 |
| Diagnostic exam of bladder and urethra using an endoscope | 21 | $1,448 | $69 |
| Fitting and insertion of vaginal support device | 27 | $1,200 | $34 |
| Insertion of device into abdomen with pressure and urine flow rate study | 26 | $931 | $36 |
| Electronic assessment of bladder emptying | 26 | $97 | $4 |
2018: 10 services
| New patient visit (45+ min) | 61 | $6,490 | $106 |
| Return visit (30+ min) | 70 | $5,001 | $60 |
| Short return visit (20+ min) | 81 | $4,086 | $40 |
| Long return visit (40+ min) | 32 | $3,537 | $96 |
| New patient visit (60+ min) | 20 | $2,867 | $143 |
| Fitting and insertion of vaginal support device | 47 | $2,073 | $36 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 20 | $2,069 | $103 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $858 | $61 |
| Insertion of device into abdomen with pressure and urine flow rate study | 20 | $726 | $36 |
| Electronic assessment of bladder emptying | 21 | $87 | $4 |
2017: 9 services
| New patient visit (45+ min) | 62 | $6,440 | $104 |
| Return visit (30+ min) | 65 | $5,433 | $66 |
| Short return visit (20+ min) | 65 | $3,856 | $40 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 28 | $3,127 | $112 |
| New patient visit (60+ min) | 17 | $2,500 | $147 |
| Long return visit (40+ min) | 21 | $2,391 | $100 |
| Fitting and insertion of vaginal support device | 29 | $1,103 | $37 |
| Insertion of device into abdomen with pressure and urine flow rate study | 28 | $1,015 | $36 |
| Electronic assessment of bladder emptying | 28 | $106 | $4 |
2016: 7 services
| New patient visit (45+ min) | 36 | $3,874 | $108 |
| Return visit (30+ min) | 38 | $3,152 | $64 |
| Short return visit (20+ min) | 53 | $2,440 | $39 |
| Long return visit (40+ min) | 16 | $1,585 | $99 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $1,066 | $89 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $394 | $36 |
| Electronic assessment of bladder emptying | 13 | $53 | $4 |
2015: 7 services
| New patient visit (45+ min) | 43 | $4,158 | $97 |
| Return visit (30+ min) | 52 | $4,042 | $66 |
| Short return visit (20+ min) | 36 | $1,855 | $37 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $1,195 | $109 |
| Fitting and insertion of vaginal support device | 17 | $677 | $40 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $394 | $36 |
| Electronic assessment of bladder emptying | 11 | $42 | $4 |
2014: 3 services
| New patient visit (45+ min) | 31 | $3,353 | $108 |
| Return visit (30+ min) | 36 | $2,774 | $62 |
| Short return visit (20+ min) | 51 | $2,456 | $42 |
2013: 8 services
| New patient visit (45+ min) | 46 | $4,415 | $96 |
| Short return visit (20+ min) | 66 | $3,615 | $40 |
| Return visit (30+ min) | 38 | $3,054 | $64 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 16 | $1,535 | $96 |
| Fitting and insertion of vaginal support device | 23 | $1,001 | $36 |
| Insertion of device into abdomen with pressure and urine flow rate study | 15 | $511 | $34 |
| Short return visit | 18 | $365 | $20 |
| Electronic assessment of bladder emptying | 14 | $50 | $4 |
Drugs they prescribed that Part D paid
$37,095
Pharmacies billed $37,095 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 147) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
105 generic and 42 brand-name prescriptions · $37,095 in drug cost · 31 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 24 | $18,147 | $756 |
| Myrbetriq | 12 | $13,288 | $1,107 |
| Estradiol | 53 | $3,103 | $59 |
| Cephalexin | 18 | $574 | $32 |
| Oxybutynin Chloride Er | 17 | $332 | $20 |
Year by year
| 2024 | 147 | 53 | 0% (0) | 29% | $37,095 |
| 2023 | 108 | 51 | 0% (0) | 37% | $31,413 |
| 2022 | 63 | 32 | 0% (0) | 30% | $8,147 |
| 2021 | 138 | 60 | None | 32% | $25,420 |
| 2020 | 128 | 52 | None | 31% | $24,141 |
| 2019 | 210 | 79 | 0% (0) | 23% | $27,590 |
| 2018 | 196 | 72 | 0% (0) | 26% | $28,249 |
| 2017 | 149 | 48 | 0% (0) | 19% | $19,678 |
| 2016 | 79 | 32 | 0% (0) | 30% | $10,785 |
| 2015 | 41 | 23 | None | None | $7,077 |
| 2014 | 79 | 37 | None | 38% | $9,109 |
| 2013 | 107 | 44 | None | 39% | $13,527 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Gemtesa | 23 | $15,053 | $654 |
| Myrbetriq | 14 | $11,506 | $822 |
| Estradiol | 26 | $2,828 | $109 |
| Oxybutynin Chloride Er | 15 | $567 | $38 |
2022: 2 drugs
| Estradiol | 18 | $3,013 | $167 |
| Nitrofurantoin Mono-Macro | 16 | $179 | $11 |
2021: 4 drugs
| Myrbetriq | 20 | $9,506 | $475 |
| Estradiol | 41 | $6,910 | $169 |
| Nitrofurantoin Mono-Macro | 17 | $226 | $13 |
| Cephalexin | 14 | $92 | $7 |
2020: 5 drugs
| Estradiol | 33 | $7,880 | $239 |
| Myrbetriq | 11 | $4,148 | $377 |
| Oxybutynin Chloride Er | 22 | $1,172 | $53 |
| Estradiol (Once Weekly) | 13 | $1,156 | $89 |
| Nitrofurantoin Mono-Macro | 15 | $211 | $14 |
2019: 4 drugs
| Estradiol | 47 | $8,509 | $181 |
| Oxybutynin Chloride Er | 40 | $1,510 | $38 |
| Trospium Chloride | 12 | $832 | $69 |
| Nitrofurantoin Mono-Macro | 26 | $448 | $17 |
2018: 6 drugs
| Vesicare | 16 | $7,962 | $498 |
| Myrbetriq | 13 | $7,005 | $539 |
| Estradiol | 17 | $3,712 | $218 |
| Oxybutynin Chloride Er | 38 | $1,552 | $41 |
| Trospium Chloride | 26 | $1,139 | $44 |
| Nitrofurantoin Mono-Macro | 16 | $287 | $18 |
2017: 4 drugs
| Estrace | 17 | $4,833 | $284 |
| Trospium Chloride | 37 | $3,356 | $91 |
| Oxybutynin Chloride Er | 30 | $1,062 | $35 |
| Nitrofurantoin Mono-Macro | 14 | $244 | $17 |
2016: 2 drugs
| Tolterodine Tartrate Er | 11 | $1,485 | $135 |
| Oxybutynin Chloride Er | 16 | $295 | $18 |
2014: 1 drug
| Estrace | 14 | $2,333 | $167 |
2013: 5 drugs
| Premarin | 12 | $2,186 | $182 |
| Estrace | 13 | $1,833 | $141 |
| Oxybutynin Chloride Er | 19 | $1,416 | $75 |
| Vagifem | 11 | $1,028 | $93 |
| Sulfamethoxazole-Trimethoprim | 12 | $65 | $5 |
Money from drug and device companies
$44 in 2025
| 2025 | 1 | 2 | None | $44 |
| 2024 | 2 | 13 | None | $1,670 |
| 2023 | 1 | 1 | None | $26 |
| 2020 | 1 | 1 | None | $25 |
| 2019 | 2 | 3 | None | $151 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bluewind Medical | Revi | $44 | 2 payments
|
See all 2 published payments
| Bluewind Medical | Meals · 2025-10-24 | Revi | $19 |
| Bluewind Medical | Meals · 2025-06-13 | Revi | $25 |
See earlier years (2024, 2023, 2020, 2019)
2024: $1,670
| Axonics | Axonics | $1,525 | 12 payments
|
| Coloplast | Altis | $145 | 1 payment
|
2023: $26
| Boston Scientific | None | $26 | 1 payment
|
2020: $25
| Allergan | Botox | $25 | 1 payment
|
2019: $151
| Allergan | Botox Cosmetic | $132 | 2 payments
|
| Ferring Pharmaceuticals | Nocdurna | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1023151115
- Licence
- CA G76784California G76784: Current · expires 2026-12-31
- Trained
- Stanford University School of Medicine, 1991
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X); Federal specialty code 207VG0400X (207VG0400X)
- Mailing address
- 1804 Embarcadero Rd, Ste 100, Palo Alto, CA, 94303
- NPI first listed
- 2007-02-15
- NPI last updated
- 2024-04-19
- NPI record certified
- 2024-04-19
This is when the NPI record was last certified, not a medical board exam.